Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: Clinical outcomes, impacts of sex and menses - MD Linx
Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: Clinical outcomes, impacts of sex and menses MD Linx
Infection and Drug Resistance — Sobel JD, et al. | July 26, 2019. Advertisement. Researchers examined the efficacy of high dose vaginal metronidazole therapy ...
Comments
Post a Comment